跳至主要内容
临床试验/IRCT20230222057495N10
IRCT20230222057495N10尚未招募Unknown

Bioequivalence study of mefenamic acid 500 mg tablets of Darou Darman Parmida pharmaceutical company compared to mefenamic acid 500 mg of Pfizer in Turkey on healthy volunteers.

Darou Darman Parmida Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Healthy volunteers aged between 18 and 55 years.
  • Body mass index less than 30 kg per square meter.
  • All volunteers must be non-smokers.

排除标准

  • Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg.
  • Consumption of any drugs, alcohol or tobacco products within 2 weeks before receiving the drug

研究者

发起方
Darou Darman Parmida Pharmaceutical Company

相似试验